On the US listing, AstraZeneca PLC American depositary shares most recently closed at 162.89 USD on the New York Stock ...
AstraZeneca stock advanced in London trading on September 18, 2026 after CEO Pascal Soriot bought 60,000 shares at GBP 121.02 ...
AstraZeneca (AZN) gains as CEO buys £7.26M in shares and EU committee recommends Klygefa approval for myasthenia gravis treatment in adults.
AstraZeneca has raised €2.55 billion through its financing arm, AstraZeneca Finance LLC, with four euro-denominated note issues that have been admitted to trading on the London Stock Exchange’s Main ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
One of the UK's most valuable listed companies is to sell its shares directly on the rival New York Stock Exchange, in a move ...
An announcement from AstraZeneca ( (GB:AZN)) is now available. AstraZeneca has tapped the euro debt markets through its finance subsidiary, pricing a €2.55 billion multi-tranche Eurobond offering that ...
AstraZeneca PLC (AZN) is a global biopharmaceutical company headquartered in Cambridge, UK AstraZeneca Finance LLC priced ...